Efficacy Study of MPC-7869 to Treat Patients With Alzheimer's
Status:
Completed
Trial end date:
2008-05-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the change in cognitive ability and activities of
daily living in patients with Alzheimer's disease (AD) as measured by specific evaluations
during 18 months of dosing.